Imagine Eyes’ customers present lectures at SFO 2020
On September 5, two users of the rtx1 Adaptive Optics retinal camera will present their clinical research at the French Society…
Imaging the RPE cell mosaic in volunteers’ eyes – ARVO video presentation
Research in retinal degenerative diseases, developments of new therapies, as well as clinical trials require precise information…
AOimage 3.4 for rtx1 enables fast evaluations of retinal disease progression
How to reduce the time needed for measuring the progression of retinal diseases? And the time required for evaluating the…
Imagine Eyes’ business operations during covid-19
Dear Customers and Partners,
All of us at Imagine Eyes deeply sympathize with the people impacted by covid-19 worldwide.…
Imagine Eyes’ AO retinal imaging system receives regulatory clearance in China
March 09, 2020, Orsay, France, and Beijing, China. Imagine Eyes' flagship product, the rtx1-e Adaptive Optics retinal camera,…
Christophe Rondeau appointed as R&D Engineer
Christophe Rondeau recently joined Imagine Eyes’ team as an R&D Engineer. “We are happy to welcome Christophe and,…
Already 168 rtx1 publications listed in our public library
The rtx1 Adaptive Optics Retinal Camera has enabled examining cellular and microvascular detail at the back of the eye. Clinical…
New: Follow-up module for the rtx1 AO retinal camera
A new software version – AOimage 3.4 – is now available for the rtx1 Adaptive Optics retinal camera. It enables tracking…
10 years of adaptive optics retinal imaging
On the occasion of the "10 years of vision research" celebration of Institut de la Vision, Prof. Kiyoko Gocho (Nippon Medical…
Presentation at the Ophthalmic Imaging Symposium in Rotterdam
Imagine Eye's CEO, Nicolas Chateau, will speak at the CORR Ophthalmic Imaging Symposium, in Rotterdam on October 4th, 2019.…